Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Argatroban pretreatment for revascularization in acute ischemic stroke
ChiCTR1800018313Phase 4Not yet recruiting
- Sponsor
- 904th Hospital of the Joint Logistic Support Force
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in ischemic stroke and cerebrovascular disease comparing Argatroban treatment group with Placebo control group (2 arms). Primary endpoint: mRS at 90 days. Planned start Oct 2018; status: not yet recruiting.
02
Drugs
argatroban
03
Conditions
ischemic strokecerebrovascular disease
Beyond the preview
Go deeper on ChiCTR1800018313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018313.